Clinical Trial Update: Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1) [Phase 2]

View source ↗

Summary

A Phase 2 pediatric trial (TRAPEDS 1) is evaluating tralokinumab monotherapy for moderate-to-severe atopic dermatitis in children; the study is currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Tralokinumab (tralokinumab)

Snippet

Sponsor: LEO Pharma | Conditions: Atopic Dermatitis | Phase 2 | Status: ACTIVE_NOT_RECRUITING